Cetera Advisor Networks’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-7,761
| Closed | -$1.43M | – | 2087 |
|
|
2021
Q2 | $1.43M | Buy |
7,761
+5,011
| +182% | +$860K | 0.02% | 660 |
|
|
2021
Q1 | $421K | Buy |
2,750
+34
| +1% | +$5.26K | 0.01% | 966 |
|
|
2020
Q4 | $424K | Sell |
2,716
-1,075
| -28% | -$138K | 0.01% | 860 |
|
|
2020
Q3 | $434K | Buy |
3,791
+2,570
| +210% | +$277K | 0.01% | 767 |
|
|
2020
Q2 | $137K | Buy |
+1,221
| New | +$130K | ﹤0.01% | 1329 |
|
|
2019
Q2 | – | Sell |
-2,716
| Closed | -$370K | – | 1250 |
|
|
2019
Q1 | $370K | Buy |
2,716
+391
| +17% | +$48.6K | 0.01% | 785 |
|
|
2018
Q4 | $229K | Sell |
2,325
-1,244
| -35% | -$147K | 0.01% | 883 |
|
|
2018
Q3 | $501K | Buy |
3,569
+475
| +15% | +$59.6K | 0.02% | 633 |
|
|
2018
Q2 | $383K | Buy |
3,094
+455
| +17% | +$53.2K | 0.02% | 557 |
|
|
2018
Q1 | $295K | Buy |
2,639
+409
| +18% | +$48.9K | 0.01% | 671 |
|
|
2017
Q4 | $268K | Buy |
2,230
+405
| +22% | +$49.3K | 0.01% | 786 |
|
|
2017
Q3 | $256K | Buy |
1,825
+35
| +2% | +$4.75K | 0.01% | 744 |
|
|
2017
Q2 | $218K | Sell |
1,790
-32
| -2% | -$3.72K | 0.01% | 814 |
|
|
2017
Q1 | $221K | Hold |
1,822
| – | – | 0.01% | 802 |
|
|
2016
Q4 | $224K | Sell |
1,822
-178
| -9% | -$21.8K | 0.01% | 756 |
|
|
2016
Q3 | $245K | Buy |
2,000
+157
| +9% | +$20.2K | 0.01% | 852 |
|
|
2016
Q2 | $215K | Buy |
1,843
+96
| +5% | +$13.6K | 0.01% | 743 |
|
|
2016
Q1 | $243K | Hold |
1,747
| – | – | 0.02% | 682 |
|
|
2015
Q4 | $334K | Hold |
1,747
| – | – | 0.02% | 571 |
|
|
2015
Q3 | $272K | Sell |
1,747
-795
| -31% | -$145K | 0.02% | 611 |
|
|
2015
Q2 | $441K | Hold |
2,542
| – | – | 0.03% | 489 |
|
|
2015
Q1 | $441K | Sell |
2,542
-963
| -27% | -$174K | 0.03% | 492 |
|
|
2014
Q4 | $648K | Buy |
3,505
+1,507
| +75% | +$279K | 0.05% | 378 |
|
|
2014
Q3 | $330K | Buy |
+1,998
| New | +$328K | 0.02% | 572 |
|
|
2014
Q2 | – | Sell |
-1,655
| Closed | -$251K | – | 830 |
|
|
2014
Q1 | $251K | Sell |
1,655
-39
| -2% | -$6.2K | 0.02% | 634 |
|
|
2013
Q4 | $225K | Buy |
+1,694
| New | +$203K | 0.02% | 647 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM